April 25, 2025

Opioid Use High in Adults With Cerebral Palsy 

Over 50% exhibited a mixed pain phenotype, researchers wrote, linking cerebral palsy pain types to increased opioid use and treatment complexity.

Conexiant

April 24, 2025

FDA Warns of Topical Finasteride Risks

The FDA has issued a safety alert on compounded topical finasteride products, citing adverse events and emphasizing the lack of regulatory approval or safety evaluation.

Conexiant

April 24, 2025

Old Drug, New Trick for Joint Pain

Can a common diabetes drug double as a treatment for knee osteoarthritis?

Conexiant

April 23, 2025

Sense of Belonging 'Critical' for Workplace Retention

Individuals who reported a neutral level of satisfaction with their sense of belonging were approximately 3 times more likely to express an intent to leave, while those who were dissatisfied were 7 times more likely to do so, compared to individuals who were satisfied with their sense of belonging.

Conexiant

April 22, 2025

Heavy Metals Found in Toothpaste

There are some "heavy metals that are essential in small quantities but could result in adverse effects if present in excess."

Conexiant

April 21, 2025

New Prescription App Reduces Migraine Days

The FDA has authorized CT-132, the first prescription digital therapeutic for episodic migraine prevention, based on clinical trial data showing reduced monthly migraine days.

Conexiant

April 21, 2025

Key Risk Factors for Shoulder Pain

"Three of the five significant risk factors for injury can be identified by objective pre-screening measures."

Conexiant

April 16, 2025

Chronic Pain: 40% Comorbidity with Depression/Anxiety

Women and younger patients with chronic pain demonstrated significantly higher rates of depression and anxiety in this comprehensive meta-analysis, with researchers noting these groups 'were most likely to have depression and anxiety.'

Conexiant

April 16, 2025

CONSORT 2025: Setting New Standards for Clinical Trial Reporting

"Readers should not have to infer what was probably done; they should be told explicitly." This principle drives the comprehensive CONSORT 2025 update, with its 7 new checklist items aimed at improving clinical trial transparency.

Conexiant